Seeking Alpha

Lpath's (LPTN.OB) Lpathomab treatment performed well in tests on mice with partially severed...

Lpath's (LPTN.OB) Lpathomab treatment performed well in tests on mice with partially severed spinal cords. Lpath says Lpathomab "reverses much of the damage caused by trauma to the nervous system," bringing scientists closer to finding a treatment for spinal cord injury. The results of the study have been published in the American Journal of Pathology. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|